The teams at Makpharm regularly explore the news and progress in many fields of medicine and follow the novelties in many therapeutic areas. It is our ambition and a huge desire to further expand our portfolio and our teams are happy to welcome new challenges, build relations with new customers and develop new strategies for launching new products. We have already added some medications beyond our major therapeutic areas to our product list. But do come back to this page for news on our latest acquisitions. We hope to update it very soon.


Breathing is an action fundamental for maintaining the human life and pulmology is the branch of medicine that deals with the diseases that affect the respiratory system. Pulmology developed as a separate branch of internal medicine during 1950s largely thanks to the need for management of tuberculosis. However, within the last half of century, it has grown into a specialty which diagnoses and manages many rare and disabling diseases, ensuring better quality of life for millions of people.

One of the rare diseases that pulmologist manage is the pulmonary artherial hypertension (PAH), a diesease of high blood pressure in the lung arteries, which affects, depending on the geographical area, approximately 11 to 26 patients per million adults. PAH is defined as the as a resting mean pulmonary artery pressure of 25 mm Hg or above. The disease is often fatal, but major progress has been made within the last decade in delaying the progression of the disease.


The immune system is capable of protecting our organism from millions of different threats, including pathogens such as bacteria and viruses, tumors and foreign particles. However, the immune system itself may cause numerous diseases by either working poorly or being too active. Immune deficiencies are a result of poor functioning of the immune system and the conditions arising from the immune system’s hyperactivity are called autoimmune diseases. Many such diseases can affect different organs are of interest to other specialists. However, clinical immunologists manage the majority of diseases of the immune system.

Autoimmune diseases are extremely rare, but the last decades have seen major progress in their diagnosis and management. Systemic sclerosis is an example of an autoimmune disease. A rare disease that affects approximately 3-12 people per million, systemic sclerosis characterised by fibrosis of the skin and internal organs and vasculopathy. Even though many of its clinical presentations are now manageable, systemic sclerosis, as well as autoimmune diseases in general, is considered an unmet medical need.